Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention A North American Perspective-2016 Update

被引:82
作者
Angiolillo, Dominick J. [1 ]
Goodman, Shaun G. [2 ,3 ,4 ]
Bhatt, Deepak L. [5 ,6 ]
Eikelboom, John W. [7 ]
Price, Matthew J. [8 ]
Moliterno, David J. [9 ,10 ]
Cannon, Christopher P. [11 ]
Tanguay, Jean-Francois [12 ]
Granger, Christopher B. [13 ]
Mauri, Laura [11 ]
Holmes, David R. [14 ]
Gibson, C. Michael [15 ]
Faxon, David P. [5 ,6 ]
机构
[1] Univ Florida, Coll Med Jacksonville, Div Cardiol, Jacksonville, FL USA
[2] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada
[3] Canadian Heart Res Ctr, Toronto, ON, Canada
[4] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada
[5] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA USA
[7] Thrombosis & Atherosclerosis Res Inst, Populat Hlth Res Inst, Dept Med, Hamilton, ON, Canada
[8] Scripps Clin, Div Cardiovasc Dis, La Jolla, CA 92037 USA
[9] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40506 USA
[10] Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA
[11] Harvard Med Sch, Brigham & Womens Hosp, Harvard Clin Res Inst, Boston, MA USA
[12] Univ Montreal, Montreal Heart Inst, Dept Med, Montreal, PQ, Canada
[13] Duke Univ, Duke Clin Res Inst, Durham, NC USA
[14] Mayo Clin, Rochester, MN USA
[15] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA
关键词
anticoagulant; antiplatelet therapy; atrial fibrillation; hemorrhage; stent; thrombosis; DUAL ANTIPLATELET THERAPY; ELUTING STENT IMPLANTATION; HEART RHYTHM ASSOCIATION; BARE-METAL STENTS; ELEVATION MYOCARDIAL-INFARCTION; CARDIOLOGY WORKING GROUP; VITAMIN-K ANTAGONISTS; BIORESORBABLE VASCULAR SCAFFOLDS; GLYCOPROTEIN IIB/IIIA INHIBITOR; PROTHROMBIN COMPLEX CONCENTRATE;
D O I
10.1161/CIRCINTERVENTIONS.116.004395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation is an emerging clinical problem. Currently, there is limited evidenced-based data on the optimal antithrombotic treatment regimen, including antiplatelet and anticoagulant therapies, for these high-risk patients with practice guidelines, thus, providing limited recommendations. Over the past years, expert consensus documents have provided guidance to clinicians on how to manage patients with atrial fibrillation undergoing percutaneous coronary intervention. Given the recent advancements in the field, the current document provides an updated opinion of selected North American experts from the United States and Canada on the treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention. In particular, this document provides the current views on (1) embolic/stroke risk, (2) ischemic/thrombotic cardiac risk, and (3) bleeding risk, which are pivotal for discerning the choice of antithrombotic therapy. In addition, we describe the recent advances in pharmacology, stent designs, and clinical trials relevant to the field. Ultimately, we provide expert consensus-derived recommendations, using a pragmatic approach, on the management of patients with atrial fibrillation undergoing percutaneous coronary intervention.
引用
收藏
页数:26
相关论文
共 206 条
[1]   ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents [J].
Abraham, Neena S. ;
Hlatky, Mark A. ;
Antman, Elliott M. ;
Bhatt, Deepak L. ;
Bjorkman, David J. ;
Clark, Craig B. ;
Furberg, Curt D. ;
Johnson, David A. ;
Kahi, Charles J. ;
Laine, Loren ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Scheiman, James ;
Sperling, Laurence S. ;
Tomaselli, Gordon F. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bhatt, Deepak L. ;
Ferrari, Victor A. ;
Fisher, John D. ;
Gardner, Timothy J. ;
Gentile, Federico ;
Hlatky, Mark A. ;
Jacobs, Alice K. ;
Kaul, Sanjay ;
Moliterno, David J. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
CIRCULATION, 2010, 122 (24) :2619-2633
[2]   Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Ageno, Walter ;
Gallus, Alexander S. ;
Wittkowsky, Ann ;
Crowther, Mark ;
Hylek, Elaine M. ;
Palareti, Gualtiero .
CHEST, 2012, 141 (02) :E44S-E88S
[3]   Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome [J].
Alexander, John H. ;
Lopes, Renato D. ;
James, Stefan ;
Kilaru, Rakhi ;
He, Yaohua ;
Mohan, Puneet ;
Bhatt, Deepak L. ;
Goodman, Shaun ;
Verheugt, Freek W. ;
Flather, Marcus ;
Huber, Kurt ;
Liaw, Danny ;
Husted, Steen E. ;
Lopez-Sendon, Jose ;
De Caterina, Raffaele ;
Jansky, Petr ;
Darius, Harald ;
Vinereanu, Dragos ;
Cornel, Jan H. ;
Cools, Frank ;
Atar, Dan ;
Luis Leiva-Pons, Jose ;
Keltai, Matyas ;
Ogawa, Hisao ;
Pais, Prem ;
Parkhomenko, Alexander ;
Ruzyllo, Witold ;
Diaz, Rafael ;
White, Harvey ;
Ruda, Mikhail ;
Geraldes, Margarida ;
Lawrence, Jack ;
Harrington, Robert A. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :699-708
[4]   Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].
Alexander, John H. ;
Becker, Richard C. ;
Bhatt, Deepak L. ;
Cools, Frank ;
Crea, Filippo ;
Dellborg, Mikael ;
Fox, Keith A. A. ;
Goodman, Shaun G. ;
Harrington, Robert A. ;
Huber, Kurt ;
Husted, Steen ;
Lewis, Basil S. ;
Lopez-Sendon, Jose ;
Mohan, Puneet ;
Montalescot, Gilles ;
Ruda, Mikhail ;
Ruzyllo, Witold ;
Verheugt, Freek ;
Wallentin, Lars ;
Darius, Harald ;
Simoons, Maarten ;
Boersma, Eric ;
DeLemos, James ;
Spencer, Fred .
CIRCULATION, 2009, 119 (22) :2877-U39
[5]  
Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI [10.1016/j.jacc.2014.09.017, 10.1161/CIR.0000000000000134, 10.1016/j.jacc.2014.10.011, 10.1016/j.jacc.2014.09.016]
[6]   Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes Results From an Updated Trial Sequential Analysis of Randomized Trials [J].
Ando, Giuseppe ;
Capodanno, Davide .
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (07) :660-670
[7]   Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies [J].
Angiolillo, D. J. ;
Gibson, C. M. ;
Cheng, S. ;
Ollier, C. ;
Nicolas, O. ;
Bergougnan, L. ;
Perrin, L. ;
LaCreta, F. P. ;
Hurbin, F. ;
Dubar, M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (01) :65-74
[8]   Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives [J].
Angiolillo, Dominick J. ;
Fernandez-Ortiz, Antonio ;
Bernardo, Esther ;
Alfonso, Fernando ;
Macaya, Carlos ;
Bass, Theodore A. ;
Costa, Marco A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) :1505-1516
[9]   Platelet Function and Genetic Testing [J].
Angiolillo, Dominick J. ;
Ferreiro, Jose Luis ;
Price, Matthew J. ;
Kirtane, Ajay J. ;
Stone, Gregg W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (17) :S21-S31
[10]   Basic Principles of Platelet Biology and Clinical Implications [J].
Angiolillo, Dominick J. ;
Ueno, Masafumi ;
Goto, Shinya .
CIRCULATION JOURNAL, 2010, 74 (04) :597-607